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Abstract
Background: Odontogenic Ameloblast-Associated Protein (ODAM) in gingival crevicular fluid (GCF) can provide
evidence of the detachment of junctional epithelium from the tooth surface by periodontitis. This study sought to
investigate the ability of ODAM to reflect the severity of periodontitis at a site-specific level; thus whether there was
a relationship between clinical diagnostic parameters and the value of ODAM in GCF was analyzed.
Methods: Eight periodontitis patients with various severities were enrolled, and the clinical parameters and samples
of GCF were obtained from 44 to 60 sites of each subject. The ODAM concentration was quantified by enzyme-linked
immunosorbent assay. Correlation analyses between clinical parameters and ODAM values and unadjusted and
adjusted (linear) mixed model analyses were performed. The accuracy of ODAM to reflect sites having a probing depth
(PD)≥ 5 mm and a positive bleeding on probing (BOP) was evaluated by receiver-operating characteristic analysis.
Results: A total of 424 GCF samples were collected. The mean ODAM concentration from each patient varied from 0.2
to 1.52 ng/ml. Correlations between PD or clinical attachment level (CAL) and ODAM values were found (p < 0.0001).
An adjusted linear mixed model showed that PD or CAL were associated with ODAM values (p < 0.05). The area under
the curve of ODAM, which reflected sites with PD≥ 5 mm and positive BOP, was 0.661 (p < 0.0001).
Conclusion: This result shows the possibility of GCF ODAM as a site-specific biomarker for periodontal tissue destruction.
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Background
Periodontitis is chronic inflammation of the periodon-
tium caused by the host’s immune response to subgingi-
val bacterial biofilm, which can lead to the irreversible
destruction of connective tissue and bone. The gingival
epithelium provides the first line of defense against
invading bacteria, forming barriers between plaque bac-
teria and gingival tissue [1].
The integrity of the junctional epithelium (JE) is there-
fore essential for maintaining a healthy periodontium.
Immunologically, the JE plays a role in protection as a
physical, chemical, and immunological barrier to protect
the underlying gingival connective tissue and bone from
exposure to bacteria and their products [1]. It has a spe-
cialized epithelial structure that attaches the gingival soft
tissue to the tooth surface consisting of an internal basal
lamina and hemidesmosomes [2]. During the progress
into periodontitis, JE detaches from the tooth surface
and migrates apically and laterally toward the space
being formed through connective tissue destruction
[3, 4]. Therefore, the detachment of JE from the tooth
surface is regarded as the hallmark in the progression
of periodontitis.
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In previous study, we reported that odontogenic
ameloblast-associated protein (ODAM) was extruded
from the JE following the onset of JE attachment loss
and was detected in gingival crevicular fluid (GCF), and
proposed that ODAM could be used as a biomarker of
periodontitis and peri-implantitis [5]. ODAM is a
secretory calcium-binding phosphoprotein expressed by
ameloblasts during the maturation stage of enamel for-
mation, and its expression persists in the reduced en-
amel organ and JE of gingiva at the erupted tooth [6]. It
was known that ODAM is implicated in the adhesion of
epithelial cells to tooth surfaces [5, 7]. Wazen et al. re-
cently showed that ODAM plays a role in maintaining
the integrity of the JE and gingival healing using an
ODAM knockout mouse model [7]. We also identified
that the adhesion of the JE to the tooth surface is regulated
via fibronectin/laminin-integrin-ODAM-ARHGEF5-RhoA
signaling, and ODAM-mediated RhoA signaling resulted in
actin filament rearrangement [5].
The diagnosis of periodontitis is currently performed
using radiography and clinical measurements, such as
probing depth (PD), clinical attachment level (CAL),
bleeding on probing (BOP), suppuration and mobility
[8]. These traditional clinical measurements not only re-
flect a history of periodontal disease but also help to de-
termine prognosis, however there is an unmet need for
an easily accessible test showing disease activity to diag-
nose periodontitis.
Extensive research has been carried out on GCF and
saliva components that might serve as potential diagnos-
tic markers for periodontitis [9, 10]. The collection of
saliva is relatively simple, safe, and non-invasive, so sal-
iva can be used as a point-of-care diagnostic tool for
periodontitis [10]. However, saliva is limited in detecting
disease activity at each individual tooth site, and so trad-
itional clinical measurements should be taken to detect
the tooth site affected by periodontitis, even if one sub-
ject is diagnosed with periodontitis using saliva. In this
respect, the diagnosis using GCF can be useful to diag-
nose the disease at specific sites. GCF contains a large
number of proteins and peptides liberated from the
underlying tissues [9, 11, 12], so the analysis of the GCF
components can reflect the disease status of individual
tooth sites.
This pilot study sought to investigate the ability of
ODAM to reflect the severity of periodontitis at a
site-specific level. The analysis of ODAM values from
single-site GCF may enable the clinician to distinguish be-
tween healthy sites and those affected by periodontitis.
For this purpose, we performed a cross-section study of
ODAM values in GCF as well as of corresponding clinical
parameters in periodontitis patients and analyzed whether
there was a relationship between clinical diagnostic pa-
rameters and the concentration of ODAM in GCF.
Methods
Patient population
Eight periodontitis patients having both sites with PD ≤
3 mm and diseased sites with PD ≥ 4 mm were partici-
pated in this study. The study protocol was approved by
the Korea University Anam Hospital, Seoul, Korea (IRB
no. ED13162) and participants provided written in-
formed consent to participate in this study. Patients with
at least 25 teeth had to have at least 5 teeth having site
with PD ≥ 4 mm, and had not received periodontal treat-
ment for the last 2 years. According to the exclusion cri-
teria, all participants had no history of systemic disease,
which could influence the prognosis of periodontitis, no
smoking, no untreated caries, no orthodontic appliances,
were not pregnant/breast-feeding, and were not treated
with medications (antibiotic, antimicrobial, and/or anti-
inflammatory drugs) during the 6 months before exam-
ination and sampling.
Clinical examination and gingival crevicular fluid (GCF)
collection
Panoramic X-rays and plaque index (PI) scores were re-
corded for all patients. Prior to measuring PD, GCF was
sampled because the gingival bleeding during the meas-
urement of PD can be sucked in GCF sampling strips.
GCF samples were obtained from teeth of one quadrant
that contained the teeth showing the most severe mar-
ginal bone loss on the panoramic X-ray view and the
contralateral quadrant of the opposite jaw. GCF samples
were obtained from four sites of each tooth (mesiobuccal,
mesiolingual, distobuccal, and distolingual sites) using ab-
sorbent paper strips (ORAFLOW, Smithtown, NY, USA).
Supragingival plaque on the tooth surface was carefully re-
moved with curettes, avoiding bleeding from the gingiva,
and each tooth site was gently dried for 10 s with com-
pressed air. Paper strip was inserted carefully into the gin-
gival sulcus/pocket until mild resistance was felt and left
in place for 30 s. There was no strip that was saturated by
GCF within the 30 s collection timeframe. In rare cases,
the strip was saturated by saliva that was not sufficiently
blocked, and those strips were discarded. Then, the strip
was transferred into a microtube containing 100 μl of
phosphate-buffered saline, and the microtubes were stored
at − 80 °C until analyzed. Red-stained strips that were
visibly contaminated with blood were discarded. After
obtaining samples of GCF, clinical parameters of PD,
CAL, and modified sulcus bleeding index (mSBI) [13]
were recorded from the same four sites of each tooth.
Therefore, a total of 428 sites were analyzed by collecting
44 to 60 recordings of clinical parameters and samples of
GCF from every 11–15 teeth of each patients. For sites
where GCF was not sampled, clinical parameters were
also recorded at four sites per tooth, including BOP in-
stead of mSBI.
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Enzyme-linked immunosorbent assay (ELISA)
The microtubes containing the paper strip were thawed
and shaken on an ELISA plate shaker for 60 min and
then centrifuged at 13,200 rpm for 3 min at 4 °C. The
supernatants were used for ELISA analysis. The total
levels of ODAM in GCF samples were assayed using an
ODAM ELISA kit according to the instructions of the
manufacturer (Cusabio Biotech, Wuhan, China). The
ODAM levels were calculated from standard curves and
expressed as the concentration calculated from the
ELISA assay itself (ng/ml per 30 s sample).The mini-
mum detection limit was 0.002 ng/ml for ODAM.
Statistical analysis
Mean values for PD, CAL, PI and mSBI and percentages
of BOP were calculated for each patient. Percentages of
sites showing PD ≤ 3 mm, PD, 4–5 mm, and PD ≥ 6 mm
were also calculated for each patient. Spearman’s rank
correlation analyses between PD, CAL, or mSBI and
ODAM values were performed. The ODAM values were
divided into four groups according to the degree of clin-
ical parameters and the differences in ODAM values
among groups were compared using ANOVA. Un-
adjusted and adjusted (linear) mixed model analysis was
performed using the non-parametric test. Adjusted
mixed models, adjusting the random effects of subject,
and the fixed effects of age, sex, mSBI, and PI were con-
sidered to identify the linear association between PD,
CAL, or mSBI and ODAM values. The accuracy of
ODAM to reflect sites having a probing depth (PD) ≥
5 mm and a positive BOP was evaluated by receiver-op-
erating characteristic (ROC) analysis and areas under
the receiver operating characteristic curve (AUC) were
calculated to compare the predictive ability of the indi-
ces, and optimal cut-off values were determined using
the Youden index to maximize the sum of sensitivity
and specificity. On the basis of the AUC statistic, the
diagnostic test can be either non-informative (AUC =
0.5), less accurate (0.5 < AUC ≤ 0.7), moderately accurate
(0.7 < AUC ≤ 0.9), highly accurate (0.9 < AUC < 1), or
perfect (AUC = 1) [14]. All statistical analyses were per-
formed using SPSS version 23.0 (SPSS, Inc., Chicago, IL,
USA) and MedCalc version 16.8 (MedCalc Mariakerke,
Belgium). The results were considered statistically sig-
nificant when p-values were less than 0.05.
Results
Characteristics of full mouth and sampled sites
Eight periodontitis patients (4 males and 4 females) with
a mean age of 57 (range, 44–74) years were enrolled in
this study. Table 1 presents the periodontal status of the
full mouth and the selected sites for GCF sampling. Each
patient had at least 18% (and up to 68.5%) of sites with a
PD ≥ 4 mm, and 60% (and up to 88.7%) of sites were
BOP-positive. The percentages for sites with PD ≤ 3 mm
among the sampling sites were calculated between 32.7
and 83.7% and that for sites with PD ≥ 6 mm were calcu-
lated between1.9 and 25.4%. The mean PD of the sam-
pling sites ranged from 3.14 ± 0.13 mm (Mean ± SD) to
4.42 ± 0.27 mm in individual patients (Table 1).
Levels of ODAM in GCF
From the total of 428 GCF sites, four could not be proc-
essed properly in sampling or experimental steps, so a
total 424 ODAM values in GCF were calculated from 8
subjects. In ELISA analysis, ODAM was not detected in
18.9% of the samples (80 among total 424 GCF samples)
because the ODAM was below the limit of detection. In
statistical analyses, these values were substituted with
zero. Figure 1 illustrates the distributions of ODAM
values in each individual patient. A broad range of
inter-individual ODAM values was found, and the mean
ODAM concentration for each periodontitis patient var-
ied from 0.2 to 1.52 ng/ml of eluate (Fig. 1).
Associations of the ODAM values in GCF with clinical
parameters
Correlations between ODAM values in GCF and clinical
parameters were determined. ODAM values were signifi-
cantly correlated with PD, CAL or mSBI (Table 2). The
required sample size was calculated using a p value com-
paring PD with ODAM in GCF, the primary outcome of
this study. A sample size of 193 achieves 80% power to
detect a Spearman correlation of 0.214 using a two-sided
hypothesis test with a significance level of 0.05. These
result was based on 5000 Monte Carlo samples from the
bivariate normal distribution under the alternative hy-
pothesis [15]. When the dropout rate was considered to
be 30%, the sample size was 276. Therefore, the analysis
of total 424 sites was sufficient to prove the relationship
between PD and the value of ODAM in GCF at
site-specific level. The ODAM value according to the de-
gree of clinical parameters was represented by a box
plot, and the differences in ODAM values among groups
classified by the severity of clinical parameters were ana-
lyzed by one-way ANOVA. The ODAM values showed a
tendency to increase as the degree of clinical parameters
increased. ODAM values were significantly different
among groups divided by the severity of PD, CAL, or
mSBI (PD; p = 0.00044, CAL; p = 0.0001, mSBI; p =
0.0041) (Fig. 2). Unadjusted and adjusted models were
used to identify linear associations between PD, CAL or
mSBI and ODAM in GCF. The unadjusted model
showed significant linear associations between ODAM
values and PD or CAL. Considering the GCF samples
were collected from 44 to 60 sites from 11 to 15 teeth
from each patient, the association between ODAM
values in GCF and clinical parameters was analyzed
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using an adjusted linear mixed model adjusted within
subject (as a random effect) and age, sex, plaque, and
mSBI (as fixed effects). Significant associations between
PD or CAL and ODAM values in GCF were also found
through adjusted model (PD; β = 0.087, p = 0.026, CAL;
β = 0.090, p = 0.005) (Table 3). Adjusted linear mixed
model revealed that the ODAM value can be an indica-
tor of PD or CAL. In sum, these findings suggest that
raised ODAM levels in GCF can represent the degree of
periodontal tissue destruction.
ROC curve analysis
The pocket with PD ≥ 5 mm is one of the most import-
ant risk indicators for periodontitis recurrence [16],
therefore, the power of ODAM to reflect sites with PD ≥
5 mm and positive BOP was evaluated by a ROC curve
and the AUC. The AUC for GCF ODAM was 0.661, the
95% confidence interval was 0.613 to 0.706, and the
p value was less than 0.0001 (Fig. 3). Optimal cut-off
values were determined using the Youden index to
maximize the sum of sensitivity and specificity. The
cut-off value of 0.25 provided sensitivities of 78.18%
and specificities of 45.50%.
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Full mouth clinical data
S1 25 100 3.12 ± 0.07 82.1 14.9 3.0 3.60 ± 0.1 0.70 ± 0.50 60.0
S2 28 112 4.05 ± 0.13 31.5 66.2 2.3 4.77 ± 0.18 0.85 ± 0.07 87.5
S3 28 112 4.25 ± 0.26 44.2 30.2 25.6 5.11 ± 0.3 0.40 ± 0.09 61.0
S4 28 112 4.17 ± 0.24 48.2 42.3 9.5 4.40 ± 0.25 0.56 ± 0.07 66.7
S5 28 112 4.56 ± 0.24 42.3 41.5 16.2 4.56 ± 0.24 0.04 ± 0.03 81.3
S6 27 108 4.21 ± 0.22 41.3 48.5 10.2 4.75 ± 0.31 0.56 ± 0.07 78.6
S7 25 100 3.93 ± 0.16 34.5 56.5 9.0 4.65 ± 0.22 0.24 ± 0.06 88.7
S8 26 104 4.14 ± 0.19 46.2 40.6 13.2 4.43 ± 0.24 0.98 ± 0.07 82.1
Clinical data of sampling sites
S1 11 44 3.14 ± 0.13 83.7 14.0 2.3 3.51 ± 0.19 0.70 ± 0.10 67.4 1.02 ± 0.13
S2 13 52 4.16 ± 0.12 32.7 65.4 1.9 4.88 ± 0.19 0.84 ± 0.09 87.0 1.84 ± 0.13
S3 15 60 4.42 ± 0.27 45.8 28.8 25.4 5.29 ± 0.3 0.36 ± 0.07 63.0 1.17 ± 0.14
S4 14 56 4.07 ± 0.24 50.0 41.1 8.9 4.32 ± 0.24 0.54 ± 0.09 64.0 1.20 ± 0.14
S5 15 60 4.38 ± 0.22 41.7 41.7 16.7 4.38 ± 0.22 0.03 ± 0.02 80.0 1.62 ± 0.14
S6 14 56 4.16 ± 0.22 40.0 49.1 10.9 4.65 ± 0.3 0.58 ± 0.09 78.0 1.31 ± 0.12
S7 13 52 4.10 ± 0.14 33.3 58.8 7.8 4.49 ± 0.19 0.20 ± 0.06 88.0 1.47 ± 0.12
S8 12 48 3.96 ± 0.18 45.8 43.8 10.4 4.19 ± 0.23 0.96 ± 0.09 81.0 1.33 ± 0.13
PD probing depth, CAL clinical attachment level, PI plaque index, BOP bleeding on probing, mSBI modified sulcus bleeding index
Fig. 1 Box-plots showing the distribution of ODAM values in each
individual patient (S1~S8). Eight periodontitis patients were sampled,
and 40–56 GCF samples were analyzed from 11 to 15 teeth from each
patient. Box plots show the medians, boxes represent the 25th
and 75th percentiles, and black dots represent the 10th and 90th
percentiles and outlier values
Table 2 Correlation of clinical parameters with ODAM in GCF
Clinical parameters Correlation coefficient p-value
PD ρ = 0.214 < 0.0001
CAL ρ = 0.232 < 0.0001
mSBI ρ = 0.111 0.0216
PD probing depth, CAL clinical attachment level, mSBI modified sulcus
bleeding index
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Discussion
This is the first study to assess the possibility of GCF
ODAM as a site-specific biomarker for periodontitis.
ODAM is involved in the adhesion of the JE to the tooth
surface and is released into the gingival crevice when the
adhesion is broken by progress into periodontitis [5]. It
was analyzed whether there was a relationship between
the value of ODAM in GCF and clinical diagnostic pa-
rameters at the same sites. As a result, ODAM appears
to serve as a novel site-specific biomarker of periodon-
titis, as demonstrated by the statistically significant asso-
ciation between the value of ODAM in GCF and the
parameters showing the degree of periodontal tissue de-
struction, PD or CAL. An adjusted linear mixed model
showed that the ODAM value in GCF can be an indica-
tor of PD or CAL. Our results suggest that ODAM in
GCF plays a role as a site-specific biomarker for deep
pockets, although additional studies including the change
of ODAM values according to treatment are needed
to determine the clinical significance of GCF ODAM.
Since the loss of epithelial adhesion from the tooth
surface is an early event in periodontal tissue destruc-
tion, it is worth verifying the potential of ODAM in
GCF as a predictive biomarker for sites that may be
vulnerable to periodontal bone loss. Based on the
potential of ODAM as a predictive marker for the
Fig. 2 The ODAM value according to the severity of clinical parameters. p-values indicate the differences in ODAM values among groups
classified by the severity of their clinical parameters (one-way ANOVA). Box plots show medians, boxes represent the 25th and 75th percentiles,
and empty dots represent the 10th and 90th percentiles. Outlier values are shown as asterisks. PD; probing depth, CAL; clinical attachment level,
mSBI; modified sulcus bleeding index
Table 3 Association between ODAM values in GCF and clinical
parameters
Variables Unadjusted model Adjusted model
β SE(β) p-value β SE(β) p-value
PDa 0.091 0.039 0.019 0.087 0.039 0.026
CALa 0.092 0.032 0.004 0.090 0.032 0.005
mSBIb 0.055 0.062 0.374 0.043 0.063 0.503
PD probing depth, CAL clinical attachment level, mSBI modified sulcus bleeding
index, adjusted linear mixed model adjusted with subject (as a random effect)
and age, sex, plaque, and mSBI (as a fixed effects)a and age, sex, plaque(as a
fixed effects)b
Fig. 3 ROC analysis of ODAM values in GCF for the reflection of sites
with PD≥ 5 mm and positive BOP. ROC analysis for GCF ODAM to
reflect the sites with PD≥ 5 mm and positive BOP were constructed
and areas under the receiver operating characteristic curve (AUC)
were calculated to compare the predictive ability of the indices.
Optimal cut-off values were determined using the Youden index
to maximize the sum of sensitivity and specificity
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diagnosis of subjects (using saliva) and sites (using GCF)
at risk for periodontitis, development of point-of-care
diagnostic tools can help to overcome the limitations of
current clinical diagnostics.
Periodontitis is developed at a site-specific level [17].
Therefore, GCF has been used as a tool for the diagnosis
of periodontitis at a site-specific level because it reflects
the site-specific severity of periodontitis. It contains a
large number of proteins and peptides derived from
underlying tissues. To date, nearly 100 different compo-
nents in GCF have been reported as possible biomarkers
for the progression of periodontitis [9, 12]. These in-
clude bacteria or bacterial products [18, 19], inflamma-
tory mediators [20], host-derived enzymes and their
inhibitors [21, 22] and soft and hard tissue destruction
products [21, 23, 24]. Although there are many candi-
dates, there has been no validation of factors involved in
the attachment of the JE to the tooth surface. ODAM
liberated from JE as a result of attachment loss can serve
as an indicator of initial periodontal breakdown. Only
extremely small volumes of fluid are available from a
single site, so GCF requires highly sensitive techniques
for quantitative analysis. In this study, ODAM was not
detected in 18.9% of the samples. It is necessary to de-
velop a highly sensitive and reliable detection tool that
can detect ODAM at low concentrations through the
development of a new antibody or aptamer.
The function of ODAM might be related to dentogin-
gival attachment [5–7]. In this study, the value of
ODAM in GCF was increased in deep periodontal
pockets. This means that pathologic JE can also express
ODAM after detachment from the tooth surface. How-
ever, in our previous study, ODAM was obviously
expressed in the normal JE of healthy teeth but was ab-
sent in the pathologic pocket epithelium of diseased
periodontium [5]. ODAM expression was reduced in the
JE of experimental periodontitis by drugs, dextran sulfate
sodium or periodontopathic bacteria (Porphyromonas
gingivalis) compared with the sham group. Moreover,
ODAM was not detected in the pocket epithelium of
teeth extracted from periodontitis patients [5]. It is not
readily explained that ODAM, which was not expressed
or expressed at low levels in the JE of gingival biopsies
from periodontitis patients, was detected at relatively
high levels in the GCF from sites with deep pockets. Re-
garding these results, Wazen et al. noted how the level
of ODAM in GCF would be maintained even though it
is no longer produced by the JE [7]. Although the pre-
cise mechanism behind the expression of ODAM in
periodontitis is unknown, one possibility may be that the
detached JE continues to produce ODAM to maintain
homeostasis for attachment to the tooth surface, and the
resulting ODAM is immediately released into the pocket
as soon as it is produced. Therefore, the ODAM may
not be observed in histologic specimens of periodontitis
models. Since the total area occupied by the pathologic
pocket epithelium capable of producing ODAM is in-
creased in periodontitis [4], the value of ODAM can be
increase in deep periodontal pockets. It is also possible
that the histological examination of the expression of
ODAM according to the severity of periodontitis is not
sufficiently verified. In our previous study, the examin-
ation of ODAM in JE from human gingival tissue was
performed on only one specimen of gingiva around teeth
extracted due to periodontitis [5]. Regarding ODAM
expression in the JE of periodontitis, Nakayama et al.
showed that ODAM gene expression was increased in
inflamed gingiva from patients with chronic periodon-
titis using DNA microarray [25]. Recently, they also re-
ported that the expression of ODAM was increased not
only at the early stage but also at the following stages in
the inflammatory JE on gingival biopsy from an experi-
mental periodontitis model induced by P. gingivalis.
They also showed that the localization of ODAM was
spread into the gingival epithelium in inflamed gingiva
using human gingival tissues [26]. To solve these dis-
crepancies, histological examination of the expression of
ODAM according to the severity of periodontitis should
be performed.
The ROC analysis and AUC calculations were used to
assess the ability of the ODAM to reflect sites with PD ≥
5 mm and positive BOP. Pockets with a PD ≥ 5 mm have
clinical significance; when compared with PD < 3 mm,
PD ≥ 5 mm represented a risk factor for tooth loss [16].
Land & Tonetti divided the risk of periodontitis recur-
rence according to the number of pockets with a PD ≥
5 mm [27]. In the analysis based on total subjects, the
AUC for ODAM was 0.661, and it was interpreted that
the ODAM value in GCF at the least has the potential
to serve as a site-specific marker of deep pockets. Add-
itional studies are needed to overcome the low sensitiv-
ity and AUC. Considering that the concentration of
ODAM in the GCF varies greatly among subjects, it is
expected that more accurate cut-off points having high
sensitivity and specificity will be determined through the
analysis of ODAM from more periodontitis patients.
There are two distinct approaches with respect to
reporting GCF mediator content and concentration: the
first is to sample GCF for a fixed time period and then
report the results either as ρg per 30-s sample or by
using the concentration as calculated from the assay
(ρg/ml per 30-s sample), and the second is to convert
the concentration calculated from the assay back into a
concentration based on the original GCF volume accord-
ing to the Periotron data [28–30]. The second approach
allows one to know the actual concentration of the medi-
ator in the GCF; however, it can have the potential for
error associated with GCF volume determination and
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calculation [28]. A recent review of clinical and technical
considerations in the analysis of GCF mentioned that re-
cent authors tend to sample for a fixed period of time
(usually 30 s) and report according to the first option de-
scribed above [28]. In this study, GCF had to be taken
from 40 to 56 sites from each patient, and as it requires a
lot of time to measure GCF volume, we adopted the
method of reporting by a fixed time period. However, to
exclude the possibility that the ODAM value is just
reflecting GCF volumes in deep pockets, the relationship
between the concentration of ODAM and GCF volume
was analyzed from an additional 30 GCF samples col-
lected from 6 independent patients. There was no correl-
ation between the concentration of ODAM and GCF
volume (p = 0.750). The correlation was analyzed using a
regression model and Stata/SE 11.1.
A limitation of this study is that GCF samples were
collected from sites that have the potential to affect one
another in the tooth. The design of the experiments was
such that GCF samples were collected from 4 sites from
each tooth, and as such, the levels of ODAM in the GCF
recovered from mesio (or disto)-buccal sites on a spe-
cific tooth cannot be considered to be completely inde-
pendent from the levels of ODAM in the GCF recovered
from the mesio (or disto)-lingual sites on the same
tooth. This limitation can lead to errors when analyzing
the correlation between the ODAM values in GCF and
the clinical parameters. Even so, ODAM in GCF was
closely associated with clinical parameters and this can
indicate the possibility of ODAM being used as a
site-specific marker of deep pockets. Analysis using the
GCF samples obtained from completely independent
sites can eliminate the related error and provide a more
precise correlation. This limitation should be corrected
in future studies.
The sample size was calculated that total 424 sites was
sufficient to prove the correlation between PD and the
value of ODAM in GCF at site-specific level, however
the study has the limitation that GCF samples are col-
lected from only 8 subjects. Moreover, the mean ODAM
concentration for each periodontitis patient varied. In
order to overcome the limitation and apply statistical re-
search methods suitable for data structures, the associ-
ation between ODAM values and clinical parameters
was analyzed using adjusted linear mixed models ad-
justed with subject effect. As a result, the adjusted model
showed that the ODAM value in GCF can be an indica-
tor of PD or CAL.
Conclusion
In this cross-sectional study of periodontitis patients hav-
ing simultaneously clinically healthy sites and diseased
sites, levels of GCF ODAM were evaluated, and the asso-
ciation between the ODAM values and traditional clinical
indices, including PD and CAL, were verified. It was
enough to confirm the possibility of ODAM as a
site-specific biomarker for periodontitis. Based on the
pilot study, additional studies should be conducted on a
large number of patients with various clinical severity to
verify the clinical significance of GCF ODAM.
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